Arcus Biosciences Inc.

NYSE: RCUS · Real-Time Price · USD
10.37
0.46 (4.64%)
At close: Aug 15, 2025, 3:59 PM

Arcus Biosciences Ratios and Metrics

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
PE Ratio
-4.74 -4.6 -5.58 52.95
PEG Ratio
0.19 -0.39 0.01 -0.39
PS Ratio
5.20 12.08 13.29 7.33
PB Ratio
2.77 3.06 2.27 3.34
P/FCF Ratio
-7.62 -4.28 3.50 -9.94
P/OCF Ratio
-7.89 -4.62 3.40 -10.96
OCF/S Ratio
-0.66 -2.62 3.91 -0.67
Debt / Equity Ratio
0.12 0.02 0.18 0.14
Quick Ratio
4.50 4.52 6.42 8.69
Current Ratio
4.50 4.52 5.53 4.10
Asset Turnover
0.22 0.11 0.08 0.24
Interest Coverage
-82.5 -170 -140 n/a
Return on Equity
-0.58 -0.66 -0.41 0.06
Return on Assets
-0.25 -0.28 -0.2 0.03
Return on Invested Capital
-0.35 -0.38 -0.24 0.04
Dividend Yield
n/a n/a n/a n/a
Payout Ratio
n/a n/a n/a n/a
Gross Profit Margin
1.00 1.00 1.00 1.00
Net Profit Margin
-1.1 -2.62 -2.38 0.14
Pretax Profit Margin
-1.1 -2.57 -2.38 0.14
Operating Profit Margin
-1.28 -2.91 -2.5 0.14
FCF Margin
n/a n/a n/a n/a
EBITDA Margin
-1.04 -2.49 -2.3 0.15